Literature DB >> 30343902

Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens.

Aleksandra Wroblewska1, Maxime Dhainaut1, Benjamin Ben-Zvi2, Samuel A Rose1, Eun Sook Park2, El-Ad David Amir3, Anela Bektesevic2, Alessia Baccarini2, Miriam Merad4, Adeeb H Rahman5, Brian D Brown6.   

Abstract

CRISPR pools are being widely employed to identify gene functions. However, current technology, which utilizes DNA as barcodes, permits limited phenotyping and bulk-cell resolution. To enable novel screening capabilities, we developed a barcoding system operating at the protein level. We synthesized modules encoding triplet combinations of linear epitopes to generate >100 unique protein barcodes (Pro-Codes). Pro-Code-expressing vectors were introduced into cells and analyzed by CyTOF mass cytometry. Using just 14 antibodies, we detected 364 Pro-Code populations; establishing the largest set of protein-based reporters. By pairing each Pro-Code with a different CRISPR, we simultaneously analyzed multiple phenotypic markers, including phospho-signaling, on dozens of knockouts. Pro-Code/CRISPR screens found two interferon-stimulated genes, the immunoproteasome component Psmb8 and a chaperone Rtp4, are important for antigen-dependent immune editing of cancer cells and identified Socs1 as a negative regulator of Pd-l1. The Pro-Code technology enables simultaneous high-dimensional protein-level phenotyping of 100s of genes with single-cell resolution.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; T cells; cancer; functional genomics; interferon gamma pathway; mass cytometry; pooled screen; protein barcodes; single cell analysis; tumor immunology

Mesh:

Substances:

Year:  2018        PMID: 30343902      PMCID: PMC6319269          DOI: 10.1016/j.cell.2018.09.022

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  37 in total

1.  A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.

Authors:  Deng Pan; Aya Kobayashi; Peng Jiang; Lucas Ferrari de Andrade; Rong En Tay; Adrienne M Luoma; Daphne Tsoucas; Xintao Qiu; Klothilda Lim; Prakash Rao; Henry W Long; Guo-Cheng Yuan; John Doench; Myles Brown; X Shirley Liu; Kai W Wucherpfennig
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

Review 2.  Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling.

Authors:  Andy J Minn; E John Wherry
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

3.  Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq.

Authors:  Diego Adhemar Jaitin; Assaf Weiner; Ido Yofe; David Lara-Astiaso; Hadas Keren-Shaul; Eyal David; Tomer Meir Salame; Amos Tanay; Alexander van Oudenaarden; Ido Amit
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

4.  Quiescent Tissue Stem Cells Evade Immune Surveillance.

Authors:  Judith Agudo; Eun Sook Park; Samuel A Rose; Eziwoma Alibo; Robert Sweeney; Maxime Dhainaut; Koichi S Kobayashi; Ravi Sachidanandam; Alessia Baccarini; Miriam Merad; Brian D Brown
Journal:  Immunity       Date:  2018-02-20       Impact factor: 31.745

5.  Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum.

Authors:  Sean C Bendall; Erin F Simonds; Peng Qiu; El-ad D Amir; Peter O Krutzik; Rachel Finck; Robert V Bruggner; Rachel Melamed; Angelica Trejo; Olga I Ornatsky; Robert S Balderas; Sylvia K Plevritis; Karen Sachs; Dana Pe'er; Scott D Tanner; Garry P Nolan
Journal:  Science       Date:  2011-05-06       Impact factor: 47.728

6.  Multiplexed ion beam imaging of human breast tumors.

Authors:  Michael Angelo; Sean C Bendall; Rachel Finck; Matthew B Hale; Chuck Hitzman; Alexander D Borowsky; Richard M Levenson; John B Lowe; Scot D Liu; Shuchun Zhao; Yasodha Natkunam; Garry P Nolan
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

7.  viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia.

Authors:  El-ad David Amir; Kara L Davis; Michelle D Tadmor; Erin F Simonds; Jacob H Levine; Sean C Bendall; Daniel K Shenfeld; Smita Krishnaswamy; Garry P Nolan; Dana Pe'er
Journal:  Nat Biotechnol       Date:  2013-05-19       Impact factor: 54.908

8.  Pseudodiploid genome organization AIDS full-length human immunodeficiency virus type 1 DNA synthesis.

Authors:  Steven R King; Nisha K Duggal; Clement B Ndongmo; Crystal Pacut; Alice Telesnitsky
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response.

Authors:  Britt Adamson; Thomas M Norman; Marco Jost; Min Y Cho; James K Nuñez; Yuwen Chen; Jacqueline E Villalta; Luke A Gilbert; Max A Horlbeck; Marco Y Hein; Ryan A Pak; Andrew N Gray; Carol A Gross; Atray Dixit; Oren Parnas; Aviv Regev; Jonathan S Weissman
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

10.  Rapid creation and quantitative monitoring of high coverage shRNA libraries.

Authors:  Michael C Bassik; Robert Jan Lebbink; L Stirling Churchman; Nicholas T Ingolia; Weronika Patena; Emily M LeProust; Maya Schuldiner; Jonathan S Weissman; Michael T McManus
Journal:  Nat Methods       Date:  2009-05-17       Impact factor: 28.547

View more
  31 in total

Review 1.  Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.

Authors:  Marliette R Matos; Seok-Man Ho; Nadine Schrode; Kristen J Brennand
Journal:  Mol Cell Neurosci       Date:  2020-07-23       Impact factor: 4.314

Review 2.  Genetic interaction networks in cancer cells.

Authors:  Barbara Mair; Jason Moffat; Charles Boone; Brenda J Andrews
Journal:  Curr Opin Genet Dev       Date:  2019-04-08       Impact factor: 5.578

3.  Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells.

Authors:  Eleni P Mimitou; Anthony Cheng; Antonino Montalbano; Stephanie Hao; Marlon Stoeckius; Mateusz Legut; Timothy Roush; Alberto Herrera; Efthymia Papalexi; Zhengqing Ouyang; Rahul Satija; Neville E Sanjana; Sergei B Koralov; Peter Smibert
Journal:  Nat Methods       Date:  2019-04-22       Impact factor: 28.547

Review 4.  CRISPR in cancer biology and therapy.

Authors:  Alyna Katti; Bianca J Diaz; Christina M Caragine; Neville E Sanjana; Lukas E Dow
Journal:  Nat Rev Cancer       Date:  2022-02-22       Impact factor: 60.716

5.  Optical Pooled Screens in Human Cells.

Authors:  David Feldman; Avtar Singh; Jonathan L Schmid-Burgk; Rebecca J Carlson; Anja Mezger; Anthony J Garrity; Feng Zhang; Paul C Blainey
Journal:  Cell       Date:  2019-10-17       Impact factor: 41.582

Review 6.  MDSC: Markers, development, states, and unaddressed complexity.

Authors:  Samarth Hegde; Andrew M Leader; Miriam Merad
Journal:  Immunity       Date:  2021-05-11       Impact factor: 31.745

7.  Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics.

Authors:  Christopher H Hulton; Emily A Costa; Nisargbhai S Shah; Alvaro Quintanal-Villalonga; Glenn Heller; Elisa de Stanchina; Charles M Rudin; John T Poirier
Journal:  Nat Cancer       Date:  2020-03-09

8.  A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.

Authors:  Ranjan Upadhyay; Jonathan A Boiarsky; Gvantsa Pantsulaia; Judit Svensson-Arvelund; Matthew J Lin; Aleksandra Wroblewska; Sherry Bhalla; Nathalie Scholler; Adrian Bot; John M Rossi; Norah Sadek; Samir Parekh; Alessandro Lagana; Alessia Baccarini; Miriam Merad; Brian D Brown; Joshua D Brody
Journal:  Cancer Discov       Date:  2020-12-17       Impact factor: 39.397

9.  Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade.

Authors:  Netonia Marshall; Keino Hutchinson; Thomas U Marron; Mark Aleynick; Linda Hammerich; Ranjan Upadhyay; Judit Svensson-Arvelund; Brian D Brown; Miriam Merad; Joshua D Brody
Journal:  Cancer Discov       Date:  2019-08-02       Impact factor: 39.397

10.  Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling.

Authors:  Christos Adamopoulos; Tamer A Ahmed; Maxwell R Tucker; Peter M U Ung; Min Xiao; Zoi Karoulia; Angelo Amabile; Xuewei Wu; Stuart A Aaronson; Celina Ang; Vito W Rebecca; Brian D Brown; Avner Schlessinger; Meenhard Herlyn; Qi Wang; David E Shaw; Poulikos I Poulikakos
Journal:  Cancer Discov       Date:  2021-02-10       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.